Unveiling the VIP: Vasoactive Intestinal Peptide’s Intriguing Role in Graves’ Disease Immunopathology  Delving deeper into the intricate world of VIP’s involvement in Graves’ disease: Mechanisms of VIP Deficiency: Autoantibody-mediated receptor downregulation: Autoantibodies targeting VPAC receptors on immune cells could render them unresponsive to VIP, effectively silencing its immunomodulatory signals. Impaired VIP production: Gut neuroendocrine cells, … Continue reading Unveiling the VIP: Vasoactive Intestinal Peptide’s Intriguing Role in Graves’ Disease Immunopathology